Terug
Dagbereik
€ 75,36
€ 77,14
52-Weeksbereik
€ 35,61
€ 94,15
Volume
1.235
50D / 200D Gem.
€ 81,21
/
€ 66,97
Vorige Slotkoers
€ 76,58
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 45,5 | 0,4 |
| P/B | 3,5 | 2,9 |
| ROE % | 8,3 | 3,8 |
| Net Margin % | 8,2 | 3,9 |
| Rev Growth 5Y % | 0,1 | 10,0 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 3,74
€ 3,68 – € 3,80
|
9,4 B | 1 |
| FY2026 |
€ 3,36
€ 3,30 – € 3,41
|
9 B | 1 |
Belangrijkste Punten
Revenue grew 0,12% annually over 5 years — modest growth
Earnings grew 72765,14% over the past year
Generating 810,00M in free cash flow
P/E of 45,47 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 15,01%
Cash machine — converts 111,16% of earnings into free cash flow
Groei
Revenue Growth (5Y)
0,12%
Revenue (1Y)-14,89%
Earnings (1Y)72765,14%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
8,31%
ROIC6,77%
Net Margin8,24%
Op. Margin15,38%
Veiligheid
Debt / Equity
0,61
Current Ratio1,18
Interest Coverage7,75
Waardering
P/E Ratio
45,47
P/B Ratio3,53
EV/EBITDA27,28
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -14,89% | Revenue Growth (3Y) | -5,89% |
| Earnings Growth (1Y) | 72765,14% | Earnings Growth (3Y) | 207,62% |
| Revenue Growth (5Y) | 0,12% | Earnings Growth (5Y) | -3,21% |
| Profitability | |||
| Revenue (TTM) | 8,84B | Net Income (TTM) | 728,65M |
| ROE | 8,31% | ROA | 3,31% |
| Gross Margin | 47,02% | Operating Margin | 15,38% |
| Net Margin | 8,24% | Free Cash Flow (TTM) | 810,00M |
| ROIC | 6,77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,61 | Current Ratio | 1,18 |
| Interest Coverage | 7,75 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 45,47 | P/B Ratio | 3,53 |
| P/S Ratio | 3,75 | PEG Ratio | 0,00 |
| EV/EBITDA | 27,28 | Dividend Yield | 0,01% |
| Market Cap | 33,13B | Enterprise Value | 37,08B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8,84B | 10,38B | 9,98B | 8,60B | 8,79B |
| Net Income | 728,65M | 1,00M | 77,00M | 784,05M | 830,15M |
| EPS (Diluted) | 1,67 | 0,00 | 0,18 | 1,82 | 1,93 |
| Gross Profit | 4,16B | 4,93B | 4,56B | 4,05B | 4,15B |
| Operating Income | 1,36B | 307,00M | 375,00M | 1,15B | 1,38B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 22,03B | 19,91B | 19,43B | 16,23B | 15,98B |
| Total Liabilities | 12,65B | 11,74B | 10,78B | 22.861,0 | 8,55B |
| Shareholders' Equity | 9,38B | 8,16B | 8,65B | 77.139,0 | 7,43B |
| Total Debt | 5,68B | 4,85B | 4,55B | 3,87B | 4,51B |
| Cash & Equivalents | 1,74B | 1,19B | 1,11B | 74,00M | 36,45M |
| Current Assets | 8,17B | 7,80B | 7,57B | 100.000,0 | 5,07B |
| Current Liabilities | 6,90B | 6,31B | 5,70B | 22.861,0 | 7,62B |